MedTrace Logo

Measurements to Assess Severity of Epicardial Stenoses

NCT00760630 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-12-27

No results posted yet for this study

Summary

Newly developed diagnostic parameters have potential to differentiate between epicardial disease and microvascular dysfunction with the help of anatomical details and physiological endpoints and can be used in present clinical settings.

Conditions

Interventions

DEVICE

FFR/CFR and IVUS

All patients with clinical indication for cardiac cath will have FFR and IVUS

Sponsors & Collaborators

Principal Investigators

  • Mohamed Effat, MD · University of Cincinnati

  • Kranthi K Kolli, MS · University of Cincinnati

  • Massoud Leesar, MD · University of Cincinnati

  • Rupak Banerjee, PhD · University of Cincinnati

  • Tarek Helmy, MD · University of Cincinnati

  • Srikara Pellukhana, BS · University of Cincinnati

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-02-24
Completion
2012-02-24
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00760630 on ClinicalTrials.gov